https://www.selleckchem.com/MEK.html
PURPOSE OF REVIEW Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic disease that affects approximately 1 in 2,500 individuals globally [Ashizawa et al. Neurol Clin Pract 2018;8(6)507-20]. In patients with DM1, respiratory muscle weakness frequently evolves, leading to respiratory failure as the main cause of death in this patient population, followed by cardiac complications [de Die-Smulders et al. Brain 1998;121(Pt 8)1557-63], [Mathieu et al. Neurology 1999;52(8)1658-62], [Groh et al. Muscle Nerve 2011;43(5)648-51]. This paper provid
Like
Comment
Share
